Our mission and strategy

We want to be one of the world’s most innovative, best performing and trusted healthcare company.

At GSK, we have an evolving business model for a sustainable future. With the aim to increase growth, reduce risk, and improve our long-term financial performance, it is focused around five strategic priorities - grow a diversified global business, deliver more products of value, simplify the operating model, create a culture of individual empowerment, and build trust.

At the same time, our strategic priorities are underpinned by our responsible business approach and we are continually listening to stakeholders to understand their expectations better.

Grow a balanced business

Our aim

We have been creating a more balanced business and product portfolio, capable of delivering sustainable sales and earnings growth and improved returns to shareholders.

This is centred on our three business areas of Pharmaceuticals, Vaccines and Consumer Healthcare.

Deliver more products of value

Our aim

We have changed our R&D organisation so that it is better able to sustain a pipeline of products that offer valuable improvements in treatment for patients and healthcare providers.

This is underpinned by a focus on improving productivity and rates of return in R&D.

Simplify the operating model

Our aim

As our business continues to change shape, we are transforming how we operate so that we can reduce complexity and become more efficient.

This frees up resources to reinvest elsewhere in the business, or return to shareholders wherever we see the most attractive returns.

Responsible business

Our aim

Being a responsible business is central to our strategy, and how we deliver success is just as important as what we achieve. Ensuring our values are embedded in our culture and decision-making helps us better meet the expectations of society.